Among the other four monoclonal antibodies (mAbs) directed against MS4A1 mentioned in IMGT/mAb-DB, there exists only a single instance where a patient suffering from refractory AChR-MG exhibited a positive response to ofatumumab. This evidence concerns the gene MS4A1 and myasthenia gravis.